Medicap Pharmacy franchise: cost, earnings and risks
2025 FDD, with page numbersSBA 7(a) data through FY2026Updated Current filing
Medicap Pharmacy in brief
Medicap Pharmacy is an independent community pharmacy franchise focused on prescriptions, immunizations, and personalized patient care. It has 59 units, all franchised (Item 20). Opening one costs $513K – $896K under the 2025 FDD; Item 19 sales: not disclosed. Our Verdict grade for Medicap Pharmacy is B (53/100, Second tier), an editorial assessment, not investment advice: SBA lenders charged off 4.8% of 104 resolved loans, but 4 units left in 2024.
Quick verdict
Compared with the median of 117 Healthcare brands.
p. 25
2025 FDD, Item 7, page 25- $200,000 As Incurred Upon Opening Various parties TOTAL (Notes 14 and 15) $513,050 - $895,653 …Quoted from the franchisor's filing; the figure on this page is rounded. Table text, cells in reading order; column headings may sit outside the quoted lines.Read page 25 free in a state registry's public copy of the filing.Get the FDD PDF · $9
Worse - Above the median: more cash needed
Better - Below the median: costs less
p. 24
2025 FDD, Item 7, page 24Read page 24 free in a state registry's public copy of the filing.Get the FDD PDF · $9Worse - Above the median: more cash needed
p. 19
2025 FDD, Item 6, page 192025, no initial fees were paid by franchisees. ITEM 6 OTHER FEES OTHER FEES TYPE OF FEE (NOTE 1) AMOUNT DUE DATE REMARKS CONTINUING LICENSE FEE 3% of Gross Sales or …Quoted from the franchisor's filing. Table text, cells in reading order; column headings may sit outside the quoted lines.Read page 19 free in a state registry's public copy of the filing.Get the FDD PDF · $9
Better - Below the median: costs less
Better - Below the median: fewer loans charged off
p. 48
2025 FDD, Item 20, page 482023, June 30, 2024 and June 30, 2025 Outlet Type Year Ended Outlets at the Start of the Year Outlets at the End of the Year Net Change Franchised June 30, 2023 74 67 -7 June 30, 2024 67 63 -4 June 30, 2025 63 59 …Quoted from the franchisor's filing. Table text, cells in reading order; column headings may sit outside the quoted lines.Read page 48 free in a state registry's public copy of the filing.Get the FDD PDF · $9
Better - Above the median: larger system
Review - median 0.0%: read the Item 20 exits
Item 12
2025 FDD, Item 12Read Item 12 free in a state registry's public copy of the filing (where).Get the FDD PDF · $9Worse - no protection
p. 43
2025 FDD, Item 15, page 43Read page 43 free in a state registry's public copy of the filing.Get the FDD PDF · $9Neutral - no benchmark
p. 14
2025 FDD, Item 3, page 14Read page 14 free in a state registry's public copy of the filing.Get the FDD PDF · $9Review - none name the franchisor
✓Better than median✕WorseWithin 10% or no benchmark!Read the details
Better or worse means more than 10% from the median. Blue links open the source page. Editorial assessment, not investment advice. Method
The $19 report: every fee, the 4 units that left in 2024 and attorney questions by Item, as a PDF. One-time; full refund within 7 days if the data does not match the FDD.
Compare:HealthSource Chiropracticgrade BWell Infusedgrade BBYou Laser Clinicgrade B
Quick facts, each with its FDD Item and page
- Category
- Healthcare
- Franchisor (legal entity)
- Medicap Pharmacies Incorporated, organized in Iowap. 9
- Parent company
- Medicine Shoppe International, Inc.p. 9
- Headquarters
- Ohiop. 9
- Franchising since
- 1974p. 9
- CEO
- Brad Cochranp. 13
- Franchised outlets in
- 18 states and territoriesItem 20, Table 3
- States and territories listed
- 18 (registered or offered in, not where units may open)
FranchiseVerdict grade
53/100
Second tier
53 this brand51 Healthcare medianlikely 49–57 (high confidence)
Higher is better · an editorial assessment, not investment advice
#1,564 of 3,067 graded brands
- Helps: Legal: No litigation naming the franchisor in Item 3
- Weighs on it: Unit growth: -8 franchised outlets over the two years to 2024
- Weighs on it: Transparency: Item 19 declines to disclose financial performance
2025 FDDGraded on the 2025 filing.
What does a Medicap Pharmacy franchise cost?
3.0% of sales a year
Royalty and ad fund, on top of the startup cost. Item 19 gives no usable average sales, so no yearly dollars.
p. 19
2025 FDD, Item 6, page 192025, no initial fees were paid by franchisees. ITEM 6 OTHER FEES OTHER FEES TYPE OF FEE (NOTE 1) AMOUNT DUE DATE REMARKS CONTINUING LICENSE FEE 3% of Gross Sales or …Quoted from the franchisor's filing. Table text, cells in reading order; column headings may sit outside the quoted lines.Read page 19 free in a state registry's public copy of the filing.Get the FDD PDF · $9
Cost breakdown
p. 38
2025 FDD, page 38Read page 38 free in a state registry's public copy of the filing.Get the FDD PDF · $9Source: FDD 2025 · Items 5–7 (fees and startup costs)
Do you qualify? The filing states no minimum net worth or liquid capital; check the franchisor's site for its own requirements. Ask Medicap Pharmacies Incorporated (Item 1: 7000 Cardinal Place, Dublin, Ohio 43017) and your lender what they require, and keep living costs for the first year outside the deal.
Full Item 7 breakdown12 line items
Initial investment breakdown
| Line item | Low | High | |
|---|---|---|---|
| Initial Feenot refundable | — | — | |
| Furniture, Fixtures & Equipmentnot refundable | $42K | $95K | |
| Pre-Opening Costsnot refundable | $3K | $10K | |
| Leasehold Improvementsnot refundable | $55K | $175K | |
| Signs & Installationnot refundable | $15K | $35K | |
| Opening Inventorynot refundable | $70K | $100K | |
| Grand Opening and Marketingnot refundable | $4K | $34K | |
| Accounts Receivable Financingnot refundable | $120K | $140K | |
| Computer and Pharmacy Equipmentnot refundable | $26K | $40K | |
| Retail Solutionsnot refundable | $0 | $14.2K | |
| Accreditation Costsnot refundable | $3.05K | $7.5K | |
| Additional Funds - 3 monthsnot refundable | $175K | $245K | |
| Total initial investment | $513K | $896K |
When each item is due
- Initial Fee
- Not applicable
- Furniture, Fixtures & Equipment
- Before Opening
- Pre-Opening Costs
- Before Opening
- Leasehold Improvements
- Before Opening
- Signs & Installation
- Before Opening
- Opening Inventory
- Upon or within 10-15 days after delivery
- Grand Opening and Marketing
- Before Opening
- Accounts Receivable Financing
- After Opening
- Computer and Pharmacy Equipment
- Before Opening
- Retail Solutions
- Before Opening
- Accreditation Costs
- Before Opening
- Additional Funds - 3 months
- Upon Opening
Line items extracted from FDD Item 7. Ranges reflect the franchisor's stated low and high per line. The total row is the total as printed in Item 7. Actual costs may fall outside this range depending on market and build-out scope.
Item 6 · what you pay once you are open
Ongoing fees
| Fee | Amount |
|---|---|
| RoyaltyPercentage of sales; timing as set out in Item 6. Also: $599/month flat fee alternative available if franchisee voluntarily purchases 95%+ of pharmaceuticals from Cardinal Health or affiliates | 3.0% of gross sales |
| Marketing / ad fund | 0.0% |
| Transfer fee | $1,000 |
| Total fee loadbelow the Healthcare median of 8.0% (lean) | 3.0% of sales |
How much do Medicap Pharmacy units make?
Not disclosed
What Item 19 of the filing says instead of a sales figure.
Groups, ranges and the one-unit box
Source: FDD 2025 · Item 19 (sales and earnings)
Items 6 (other fees), 7 (startup costs) and 19 (sales and earnings) · assumptions labeled
What you could make and lose: one unit
What one Medicap Pharmacy unit would ask of you, from the filing's Item 7 total and labeled assumptions.
How these figures are worked out
- Loan (assumption): 80% of the $704K Item 7 midpoint is a $563K loan, paid over 10 years at 10.5%: $91K a year. SBA 7(a)-style terms on a long-term rate; your lender sets yours. Medicap Pharmacy's past SBA 7(a) loans averaged 5.8% at approval; 7(a) rates move with the prime rate, so 10.5% is a current-rate assumption, not this brand's history.
What you put at risk
Your own cash in: about $141K Assumption (the part the loan does not cover of the $704K Item 7 midpoint), plus whatever anything Item 7 leaves out (its notes say what). The loan is $563K.
Personal guarantee. SBA 7(a) loans require a personal guarantee from anyone who owns 20% or more of the business. If the unit cannot pay, the lender can collect from you personally, which can include your savings and your home. The worst case is losing the cash you put in and still owing the rest of the loan.
Gross sales are not profit, and none of these figures is take-home pay until tax and every operating cost are paid. The assumptions are ours, not the filing's. Not investment advice.
Returns model: one unit, several units, buying an existing unit (editable, pre-filled from this filing).
Item 19 · Source: 2025 FDD · filed by Medicap Pharmacies Incorporated
Financial performance
No financial performance representation
This franchisor makes no financial performance representation in Item 19 of its FDD. Item 19 is voluntary under the FTC Franchise Rule, and this filing states that it makes none, so no revenue or earnings figures are disclosed. Declining to publish one is lawful and is not evidence of how the outlets perform. It does mean that less about this brand can be verified from its filing, and the verdict grade - an editorial assessment, not investment advice - reflects that.
Item 20 of the FDD lists current and former franchisees; asking them directly is the standard way to fill this gap.
Medicap Pharmacy SBA loans and unit growth
0 in · 4 out
-8 franchised outlets over the two years to 2024 (67 to 59, -11.9% in total, -6.2% a year compounded). Lenders, states and loans by approval year inside; the charge-off rate is the Quick verdict tile.
States and SBA detail
Source: FDD 2025 · Item 20 (outlets opened, closed and transferred)
Item 20 (outlet counts) · unit dynamics
The growth chart
- Company-owned
- 0
- Corporate units in the system
- % franchised
- 100%
- vs corporate-owned
Last fiscal year · Item 20 rates and pipeline
- Reacquired
- 0
- Franchisor bought back
- Signed, not yet open
- 0
- Item 20 Table 5
- Projected new
- 14
- Franchisor's next-year forecast
Item 20 projects a RANGE here, not a single number: the filing prints 5-14 new franchised outlets. The figure shown is the high end, 14, which is the convention every range-resolved brand on this site follows (owner ruling R91-A).
- Transfer rate
- 0.0%
- Owners selling to other franchisees
- Continuity rate
- 93.7%
- Units that stayed open
- Termination rate
- 3.4%
- Franchisor-initiated terminations
Item 20 · franchised units at year end
Franchised units fell from 67 in 2022 to 59 in 2024
Axis does not start at zero.
Source and method
Item 20 (outlet counts) Table 3 · franchised outlets in 18 states
Where franchised outlets are
Franchised outlets at year end by state, as the filing's Item 20 Table 3 counts them. Not a list of where the franchisor may sell new units.
Current outlets (count on the tile) · 18 statesNo current outlet
Current outlets (count on the tile) · 18 statesNo current outlet
59 franchised outlets at year end in 18 states (Item 20 Table 3).
A system that lost more than 10% of its franchised outlets across the Item 20 years is a red flag. Check whether closures are concentrated in specific regions.
Government records
SBA loan data
Lenders charged off 4.8% of 104 resolved SBA 7(a) loans, below the 7.3% category median. 7(a) is the SBA's main small-business loan; a resolved loan was paid in full or charged off.
- Loans on file
- 108
- SBA 7(a) loans matched to this brand, incl. those still being repaid
- Loan volume
- $24.9M
- Average loan
- $231K
- loan volume divided by loans
- Charge-off rate
- 4.8%
- 5 of 104 resolved loans
- Paid in full
- 95.2%
- of resolved loans
- Charge-off, loans approved FY2019–FY2021
- Too early to judge
- fewer than 10 resolved loans approved FY2019–FY2021
- Average interest rate
- 5.8%
- Jobs reported
- 270
- on the 70 loans approved FY1999 on; earlier loans did not record jobs
- Lender concentration
- 14%
- top lender's share
Cumulative: every 7(a) loan matched to this brand in the SBA’s FOIA files, approved FY1992 onward. Historical lending data, not predictive of future performance. How SBA charge-off rates are calculated
Benchmark: the median Healthcare brand charges off 7.3% (11 brands with a published rate, same cumulative window and source). This brand is 2.5 points below it.
Top 10 of 52 SBA lenders by loan count
| Loans | Volume | Charge-off |
|---|---|---|
| Bank of America, National Association | ||
| 15 | $1.8M | 7.1%14 resolved |
| Stearns Bank National Association | ||
| 13 | $3.6M | 7.7%13 resolved |
| Newtek Small Business Finance, Inc. | ||
| 8 | $1.8M | Too few8 resolved |
| JPMorgan Chase Bank, National Association | ||
| 5 | $1.7M | Too few5 resolved |
| Live Oak Banking Company | ||
| 4 | $2.2M | Too few4 resolved |
| First-Citizens Bank & Trust Company | ||
| 3 | $471K | Too few3 resolved |
| Wells Fargo Bank National Association | ||
| 3 | $320K | Too few3 resolved |
| Alerus Financial, National Association | ||
| 2 | $375K | Too few2 resolved |
| BNY Mellon, National Association | ||
| 2 | $138K | Too few2 resolved |
| Capital One, National Association | ||
| 2 | $85K | Too few2 resolved |
A lender’s rate counts only its resolved loans, the loans that have finished (paid in full or charged off); a 0.0% often means few of its loans have finished. Under 10 resolved loans, the rate reads “Too few”.
Loans by state and charge-offs by approval year on the Medicap Pharmacy SBA loan report.
Explore lender portfolios on Bank Reports or regional data on State Reports.
Medicap Pharmacy lawsuits and risks
Item 3: 7 matters
Main risk: a shrinking system. Franchised outlets fell from 67 to 59 over the two years to 2024.
p. 14
2025 FDD, Item 3, page 14Read page 14 free in a state registry's public copy of the filing.Get the FDD PDF · $9Cases and checks
Things to check before you sign (3)
- Net -4 franchised outlets in 2024 (Item 20, outlet counts). Ask owners why outlets closed.
- The franchisor keeps the right to compete inside your territory (Item 12, territory).
- You waive a jury trial in disputes with the franchisor (Item 17, renewal, termination and disputes).
Checked and clear: no auditor doubt that the franchisor can keep operating, no pending lawsuit naming the franchisor, SBA charge-off rate 4.8%, below the 7.3% category median, no supplier rebates to the franchisor, no rule that the owner must run it personally and the full filing on file.
Source: SBA 7(a) FOIA · FDD Items 3, 21
Verdict grade + FDD Items 3 (litigation), 4 (bankruptcy), 8 (required suppliers), 16 (what you may sell), 21 (audited financials)
Risk and legal
Grade B: Second tier, 53/100 (category median 51); the full grade is at the top of the page.
How the grade is built
Main risks: shrinking franchise system with declining units, undisclosed financials, parent company regulatory/litigation exposure, and franchisee payment disputes signal fundamental operational and profitability challenges.
Litigation (Item 3)
Subject: officers or affiliates. The franchisor is not a named party in these cases.
No Medicap-specific litigation disclosed. Three MSI affiliate arbitrations against franchisees for failure to pay fees under franchise agreements, all settled. Extensive Cardinal Health parent litigation including SEC settlement ($35M penalty), national opioid settlement ($6.3B+ total), and IVC filter product liability ($275M settlement). All resolved or ongoing at parent level only.
Bankruptcy (Item 4)
None disclosed
Audited financials (Item 21)
Yes · Ernst & Young LLP
Item 21 revenue, parent or group statements
The revenue figures are in the Franchisor tab, under The franchisor.
Franchisor entity revenue (not unit-level)
Item 21 financial statements are the consolidated financials of the franchisor's ultimate parent and guarantor, Cardinal Health, Inc. and subsidiaries (not Medicap Pharmacies Incorporated standalone), audited by Ernst & Young LLP. Figures in millions: total revenue FY2025 $222,578M, FY2024 $204,765M; net earnings attributable to Cardinal Health FY2025 $1,561M; total assets $53,122M; total shareholders' deficit (negative net worth) of $2,634M at June 30, 2025.
ⓘ These are the parent company's consolidated financials (the parent guarantees the franchisor), not this brand's standalone results; the figure reflects the whole corporate group, not this brand alone.
Supplier relationship · Items 8 & 16
Ask what the franchisor earns on the supplies it sells you or the rebates it takes (Item 8).
- Franchisor sells you products: Yes
- Franchisor takes supplier rebates: No
- Must buy proprietary products: No
- Restricted to system-approved products: No
- Franchisor negotiates, or may negotiate, supplier terms: No
Notes from the filing review · not the score inputs
- 01MEDNo average gross sales or net income disclosure (missing Item 19) prevents assessment of actual earnings potential and ROI
- 02HIGHParent company Cardinal Health faces SEC enforcement action for accounting practices and major opioid/IVC filter litigation exposing franchisees to reputational and operational risk
- 03HIGHMSI litigation against franchisees for non-payment indicates cash flow problems among existing operators
- 04MINORUnprotected territory creates direct competition risk between franchisees in same market
- 05MINORRoyalty structure ($599/month floor) may be disproportionate burden if franchisee operates below breakeven
- 06MINOR5-year term is relatively short without renewal clarity, creating exit risk after initial investment period
Severity inferred from the FDD text · not a regulatory classification
Medicap Pharmacy franchise agreement terms
5 years
Initial term (Item 17); renewal, territory, training and suppliers inside.
All contract terms
Source: FDD 2025 · Items 11, 12, 17
FDD Items 12 (territory), 15 (owner participation) and 17 (renewal, termination and disputes)
Contract and territory detail
| Allowed renewals | 1 |
|---|---|
| Protected territory | No |
| Exclusive territory | No |
| Online sales rights | Allowed |
| Franchisor can compete | Yes |
| Who runs it (Item 15) | A manager may run it |
| Right of first refusal | No |
| Transfer requires consent | Yes |
| Termination notice | 90 days |
| Termination grounds | 3 |
| Mandatory arbitration | No |
| Arbitration location | Columbus, Ohio (if court mandates arbitration) |
| Jury trial waiver | Yes |
| Governing law | OH |
Items 10 (financing), 11 (training and support)
Training and operations
- Classroom training
- 0 hrs
- On-the-job training
- 0 hrs
- Training location
- On-site at franchisee's restaurant and corporate training facility
- Ongoing training
- Optional
- Time to open
- 6–12 mo
- From signing to launch (FDD p.34)
- Site selection
- Franchisee
- Franchisor financing
- Not offered
- Item 10
Items 5 (initial fees) & 11 (training and support)
Franchisor support
Medicap Pharmacy pros and cons
1 pro · 2 cons
Helped by legal record. Held back by unit growth and transparency.
Pros, cons and peers
Why a B, factor by factor
- Financial health NeutralAudited financials; no going-concern doubt; statements are the parent's, so this stays near neutral
- Unit economics NeutralNo Item 19 sales figure to set against the investment, so neutral
- Unit growth Weighs on it, weakest dimension-8 franchised outlets over the two years to 2024 (67 to 59, -11.9% in total, -6.2% a year compounded); turnover 6.8%
- Scale Neutral59 franchised units; franchising since 1974
- Legal HelpsNo litigation naming the franchisor in Item 3
- Transparency Weighs on itItem 19 declines to disclose financial performance; audited financials
- Adjustments after the six dimensions (+5 points)SBA loan record: the SBA charge-off rate (4.8% on 104 resolved loans) is between 2% and 5%, a range the score counts in a brand's favour, so it added 5 points.
From the six scored dimensions, an editorial assessment, not investment advice. How the score is built
Who are you contracting with?
Medicap Pharmacies Incorporated, owned by Medicine Shoppe International, Inc.
Item 1 (the franchisor) · who you're contracting with
The franchisor
Corporate structure & franchisor financials
- Legal entity
- Medicap Pharmacies Incorporated
- Parent company
- Medicine Shoppe International, Inc.
- p. 9
- Ultimate parent
- Cardinal Health, Inc.
- p. 9
- CEO title
- President, MSI and Medicap; Cardinal Health Executive Vice President, Pharmaceutical and Specialty Distribution
- Brad Cochran
- CEO experience
- 26 yrs
- Years in role or industry
- Incorporated in
- IA
- HQ
- 7000 Cardinal Place, Dublin, Ohio 43017
- Auditor
- Ernst & Young LLP
- Audited financials
- Item 21 revenue, parent or group statements
- $222.6B
- latest fiscal year in the 2025 FDD; $226.8B the year before
- Management churn noted
- Frequent turnover
- Item 2 disclosed frequent executive changes
Affiliated brands
- MSI
Other brands the franchisor or its parent operates (Item 1).
Same owner · FDD Item 1, p. 9
1 other brand on this site names Cardinal Health, Inc. as parent or ultimate parent in its own FDD.
- Medicine Shoppe (grade B)
Grouped by the owner's name as each filing prints it (this page: the 2025 FDD). Spelling variants of the same group may be listed apart; a brand is never grouped with an owner its filing does not name.
| Brand | Investment (Item 7) | Item 19 average | Units (Item 20) |
|---|---|---|---|
| HealthSource Chiropractic(B) | $436K – $635K | $610K | 128 |
| Well Infused(B) | $324K – $1.0M | $1.4M | 2 |
| BYou Laser Clinic(B) | $490K – $917K | $868K | 6 |
| beem® Light Sauna(B) | $393K – $718K | $466K | 39 |
| HEALTH MART Drugstore(B) | $262K – $799K | Not stated | 4,544 |
| Brand | Investment (Item 7) | Item 19 average | Units (Item 20) |
|---|---|---|---|
| Medicine Shoppe(B) | $513K – $896K | Not stated | 271 |
Each brand's own latest FDD. Item 19 averages are gross sales, not profit, and brands measure them differently.
Next steps before you buy a Medicap Pharmacy franchise
3 steps
Read the FDD 14 days before you sign, call current and former owners, talk to an SBA lender and a franchise attorney.
The Medicap Pharmacy FDD report · $19
- Every fee and Item 7 cost we read from the filing, by Item
- The 4 units that left in 2024, and the questions to ask about them
- Questions for your attorney, by Item
Full refund within 7 days if the data does not match the FDD. · sample
Compare before you decide
- Medicap Pharmacy vs HealthSource Chiropractic
- Medicap Pharmacy vs Well Infused
- Medicap Pharmacy vs BYou Laser Clinic
Already own a Medicap Pharmacy? Benchmark your numbers against the filing
Steps and questions to ask
What to do next
Step 1: Read the FDD itself.
Free: the franchisor must give you its current FDD at least 14 days before you sign or pay. Or read the public copy in a state registry (Wisconsin, Minnesota, California). What to read first.
Step 2: Talk to current and former owners.
Free: Item 20 of the FDD lists every current owner and those who left last year, most with a phone number. Questions to ask.
Step 3: Talk to an SBA lender.
Free: the SBA's Lender Match, or the lenders already lending to this brand in the SBA section. Ask what you would personally guarantee and what the monthly payment would be. If you plan to use retirement savings, ask a CPA about the rules for that first.
Research steps, not investment or legal advice. Before you sign, have a franchise attorney review the FDD and the agreement: your state bar's lawyer referral service can name one, and many offer a short first consultation.
Franchisee contacts
We hold no owner list for this brand. Item 20 of the FDD lists the current and former owners; the free FDD is the source.
Medicap Pharmacy franchise FAQ
7 answers
Cost, fees, earnings, closures, ownership, SBA loans and territory, each answered with the number first.
All questions
Frequently asked questions
How much does it cost to open a Medicap Pharmacy franchise?
Per the 2025 FDD, the total investment to open a Medicap Pharmacy franchise ranges from $513K to $896K. This is the Item 7 total in the Franchise Disclosure Document (FDD): the startup costs the franchisor lists, such as build-out, equipment, inventory and working capital. It usually leaves out buying land or a building; Item 7's notes say what is excluded.
What do Medicap Pharmacy franchise owners earn?
Medicap Pharmacy makes no financial performance representation in Item 19 of its FDD - a voluntary item under the FTC Franchise Rule - so no gross sales figures are disclosed. Declining to publish one is lawful and is not evidence of how the outlets perform. It does mean that less about this brand can be verified from its filing, and the verdict grade - an editorial assessment, not investment advice - reflects that. Item 20 of the FDD lists current and former franchisees; asking them directly is the standard way to fill this gap.
Who owns Medicap Pharmacy?
Medicap Pharmacy is franchised by Medicap Pharmacies Incorporated. Its parent company is Medicine Shoppe International, Inc.. The ultimate parent named in the FDD is Cardinal Health, Inc.. Source: FDD Item 1, 2025 filing.
What is Item 19 in the Medicap Pharmacy FDD?
The FDD section where a franchisor may disclose financial performance of its outlets. Disclosure is optional and formats vary; figures are typically gross sales, which is revenue before expenses, not profit. The Medicap Pharmacy FDD does not make an Item 19 financial performance representation, so this page shows no earnings figure.
What is Medicap Pharmacy's franchise failure rate?
There is no published franchise failure rate. What is measurable is Medicap Pharmacy's SBA charge-off rate: 4.8% on 104 resolved loans. Put plainly: 1 in 21 SBA 7(a) loans to Medicap Pharmacy owners charged off (5 of 104 resolved loans, approved since FY1992). The SBA charge-off rate is the share of a brand's resolved SBA 7(a) loans to its franchisees that the SBA wrote off, including purchased guarantees. Resolved means paid in full or charged off; active loans are excluded because their outcome is not yet known. It is a lending outcome, not a count of closed businesses. A franchisee can repay and close, or default and keep trading.
How many Medicap Pharmacy franchise locations are there?
Per the 2025 FDD, Medicap Pharmacy has 59 franchised units and 0 company-owned (59 in all). In the latest year, the number of franchised outlets fell by 4 (0 opened, 4 closed).
Is Medicap Pharmacy a good franchise to buy?
FranchiseVerdict gives Medicap Pharmacy a B Verdict grade (Second tier) with a verdict score of 53 out of 100 (higher is better), an editorial assessment, not investment advice. Helped by legal record (no litigation naming the franchisor in Item 3). Held back by unit growth (-8 franchised outlets over the two years to 2024: 67 to 59, -11.9% in total, -6.2% a year compounded) and transparency (Item 19 declines to disclose financial performance). The “Why a B” section on this page lists all six dimensions and any adjustment. Speak with current franchisees before making any investment decision.
Sources
2025 FDD
Every FDD figure is read from the filing, with its page (4 of 4 headline figures cite one). Loans: SBA 7(a) records.
All sources and page cites
Source pages
- FDD 2025, Item 3, p. 14 Litigation
- FDD 2025, Item 6, p. 19 Royalty, Ongoing fees
- FDD 2025, Item 7, p. 24 Working capital
- FDD 2025, Item 7, p. 25 Total investment
- FDD 2025, Item 15, p. 43 Owner-Operator
- FDD 2025, Item 20, p. 48 System size
Open a chip beside a figure for the line it reads. The filing itself is free in a state registry's public copy.
FDD issued: · Data extracted: · Last cited check: · Staleness risk: medium (issued 12 to 24 months ago; a newer filing is likely on file)
Evidence for the headline figures: strong✓ Investment (Item 7)✓ Item 19 status✓ Units and owners (Item 20)✓ SBA loan coverage✓ Litigation (Item 3)✓ Financial statements (Item 21)✓ Franchisor identityhow this is scored4 of 4 headline figures on this page cite a page of the filing.
- [1]U.S. Small Business Administration: 7(a) loan-level disclosures released under the Freedom of Information Act. How the rate is computed: methodology.
- [2]Medicap Pharmacy 2025 Franchise Disclosure Document, Items 5 (initial fees), 6 (recurring fees), 7 (initial investment), 19 (financial performance), 20 (unit counts and turnover), filed with state franchise regulators under FTC rule 16 CFR 436. Filed by Medicap Pharmacies Incorporated. Read this filing.
How each headline figure is sourced
Verified: printed in the filing and restated elsewhere in it, or re-derived from the table's own arithmetic. Cited, not corroborated: printed on the page named, with nothing else in our record restating it. Not cited: published from our reading of the filing; the page has not been located.
- [3]How the verdict grade is built: methodology.
Recent checks against the filing (8)
- · Franchisor as plaintiff · read from page 15 of the 2025 FDD
- · Initial franchise fee · read from page 24 of the 2025 FDD
- · Franchise fee high · read from page 24 of the 2025 FDD
- · Franchise fee low · read from page 24 of the 2025 FDD
- · Franchisor as defendant · read from page 15 of the 2025 FDD
- · Financials are parent level · read from page 233 of the 2025 FDD
- · Franchisor revenue year 2 · read from page 233 of the 2025 FDD
- · Largest settlement amt · read from page 16 of the 2025 FDD
By the FranchiseVerdict editorial team · Reviewed against the 2025 FDD · Website ·
Cite this page
Citation
FranchiseVerdict. "Medicap Pharmacy franchise profile." Source: 2025 Franchise Disclosure Document and SBA 7(a) loan data. Updated November 14, 2026. https://franchiseverdict.com/brand/medicap-pharmacy
Link for a web page
<a href="https://franchiseverdict.com/brand/medicap-pharmacy">Medicap Pharmacy franchise profile (FranchiseVerdict)</a>
Free to quote with a link. Figures come from the filing or federal loan data named above; grades are FranchiseVerdict's editorial assessment, not investment advice. Press and data requests: press@franchiseverdict.com
This information is provided for research purposes only and does not constitute financial, legal, or investment advice. Verify all figures with the franchisor's current Franchise Disclosure Document before making any investment decision.